User profiles for Robert Ulrich

Robert G.Ulrich

- Verified email at viroforgetek.com - Cited by 4545

Robert J. Ulrich

- Verified email at nyulangone.org - Cited by 527

Robert N. Ulrich

- Verified email at g.ucla.edu - Cited by 119

[HTML][HTML] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

…, AB Troxel, TY Tseng, NA Turner, RJ Ulrich… - Nature …, 2021 - nature.com
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs)
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms

…, KU Saikh, BG Stiles, CJ Roy, RG Ulrich… - Journal of Infectious …, 2005 - academic.oup.com
A new anthrax vaccine under clinical investigation is based on recombinant Bacillus anthracis
protective antigen (rPA). Here, we investigated microneedle-based cutaneous and nasal …

Treating COVID-19 with hydroxychloroquine (TEACH): a multicenter, double-blind randomized controlled trial in hospitalized patients

RJ Ulrich, AB Troxel, E Carmody… - Open forum …, 2020 - academic.oup.com
Background Effective therapies to combat coronavirus 2019 (COVID-19) are urgently needed.
Hydroxychloroquine (HCQ) has in vitro antiviral activity against severe acute respiratory …

Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine

…, VJ Sullivan, B Dyas, CJ Roy, RG Ulrich - Infection and …, 2006 - Am Soc Microbiol
The recombinant protective antigen (rPA) of Bacillus anthracis is a promising anthrax vaccine.
We compared serum immunoglobulin G levels and toxin-neutralizing antibody titers in …

Evaluation of the effect of syringe surfaces on protein formulations

…, BM Ford, KD Mar, VJ Sullivan, RG Ulrich… - Journal of …, 2011 - Elsevier
Packaging of drugs in prefillable syringes offers considerable advantages over conventional
vials. Almost all major biotech molecules are available on the market today in prefilled …

Antibody responses to Zika virus infections in environments of flavivirus endemicity

…, DM Dudley, DH O'Connor, RG Ulrich - Clinical and Vaccine …, 2017 - Am Soc Microbiol
Zika virus (ZIKV) infections occur in areas where dengue virus (DENV), West Nile virus (WNV),
yellow fever virus (YFV), and other viruses of the genus Flavivirus cocirculate. The …

Anthrax vaccine powder formulations for nasal mucosal delivery

…, KD Mar, JA Mikszta, CR Hwang, R Ulrich… - Journal of …, 2006 - Elsevier
Anthrax remains a serious threat worldwide as a bioterror agent. A second-generation anthrax
vaccine currently under clinical evaluation consists of a recombinant Protective Antigen (…

DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the …

…, Z Blacklock, K Jost, S Locke, RF Ulrich… - Journal of Clinical …, 1995 - Am Soc Microbiol
Nineteen reference and 156 clinical strains of the genus Nocardia belonging to 12 taxonomic
groups were studied for restriction fragment length polymorphism (RFLP) by using an …

[HTML][HTML] Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination

…, G Chen, B Schweitzer, A Nalca, RG Ulrich - PLoS …, 2010 - journals.plos.org
Monkeypox is a zoonotic viral disease that occurs primarily in Central and West Africa. A
recent outbreak in the United States heightened public health concerns for susceptible human …

Human survivors of disease outbreaks caused by Ebola or Marburg virus exhibit cross-reactive and long-lived antibody responses

…, JJ Lutwama, L Lobel, JM Dye, RG Ulrich - Clinical and Vaccine …, 2016 - Am Soc Microbiol
A detailed understanding of serological immune responses to Ebola and Marburg virus
infections will facilitate the development of effective diagnostic methods, therapeutics, and …